Taxus “Peri-approval” Trial Offers Postmarket Study Model – Zuckerman
This article was originally published in The Gray Sheet
Executive Summary
FDA is encouraging PMA sponsors to file a continued-access protocol for a long-term trial that will meet postmarket study requirements following a device's approval